Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705)
2012 ◽
Vol 96
(1)
◽
pp. 74-83
◽
2006 ◽
Vol 83
(1)
◽
pp. 55-62
◽
2012 ◽
Vol 42
(3)
◽
pp. 222-225
◽
2002 ◽
Vol 32
(3)
◽
pp. 90-94
◽
2008 ◽
Vol 38
(7)
◽
pp. 501-503
◽
2003 ◽
Vol 33
(1)
◽
pp. 28-32
◽